English中文

Offstream
news



Changes

  1. The Subject Expert Committee of Central Drugs Standard Control Organisation allows Serum Institute of India to conduct trials of the Novavax COVID-19 vaccine for children aged 7 to 11 years old.
  2. The Subject Expert Committee of the Central Drugs Standard Control Organisation will allow the Serum Institute of India to conduct trials of the Novavax COVID-19 vaccine in children between the ages of 7 and 11 years.

Related